Original Article
Patient Characteristics Associated with Telemedicine Use for Diabetes Mellitus Care: Experience of a University Health System
Abstract
Objectives: The objective was to understand the characteristics of patients who used telemedicine for diabetes management to inform future implementation of telemedicine.Methods: We examined patient characteristics associated with telemedicine use for diabetes mellitus (DM) care between March 1, 2020 and April 1, 2021 (the coronavirus disease 2019 pandemic period) in a large university health system when telemedicine visits increased rapidly. Logistic regression models assessed patient characteristics associated with telemedicine visits and delays in DM process measures (hemoglobin A1c checks, nephropathy, and retinopathy evaluations) during the pandemic period after adjusting for potential confounders and corresponding values before the pandemic period (March 1, 2019–February 29, 2020).
Results: A total of 45,159 patients were seen from 987,791 visits during the pandemic period. The number of visits averaged one visit less during the pandemic period than before the pandemic period. Approximately 5.4% of patients used telemedicine during the pandemic period from 42,750 visits. The mean (standard deviation) telemedicine visit was 1.28 (0.91). Men, Asian, Black, and other race (vs White), having Medicare or uninsured (vs private insurance), were less likely to use telemedicine. Patients with more visits before the pandemic period were more likely to use telemedicine and less likely to experience a delay in DM process measures during the pandemic period. Telemedicine users were 18% less likely to experience a delay in nephropathy visits than nonusers, but without difference for other process measures.
Conclusions: Race, sex, insurance, and prepandemic in-person visits were associated with telemedicine use for DM management in a large health system. Telemedicine use was not associated with delays in hemoglobin A1c testing, nephropathy, and retinopathy assessments. Understanding reasons for not using telemedicine is important to be able to deliver equitable DM care.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Rowley WR, Bezold C, Arikan Y, et al. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag 2017;20:6–12.
2. Blonde L, Aschner P, Bailey C, et al. Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diabetes Vasc Dis Res 2017; 14:172–183.
3. Appuswamy AV, Desimone ME. Managing diabetes in hard to reach populations: a review of telehealth interventions. Curr Diab Rep 2020;20:28.
4. Tchero H, Kangambega P, Briatte C, et al. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed e-Health 2019;25:569–583.
5. Greenwood DA, Gee PM, Fatkin KJ, et al. A systematic review of reviews evaluating technology-enabled diabetes self-management education and support. J Diabetes Sci Technol 2017;11:1015–1027.
6. Hanlon P, Daines L, Campbell C, et al. Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res 2017;19:e172.
7. Timpel P, Oswald S, Schwarz PEH, et al. Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses. J Med Internet Res 2020;22:e16791.
8. Lee JY, Lee SWH. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 2018;20:492–500.
9. Giani E, Dovc K, Dos Santos TJ, et al. Telemedicine and COVID-19 pandemic: the perfect storm to mark a change in diabetes care. Results from a world-wide cross-sectional web-based survey. Pediatr Diabetes 2021;22:1115–1119.
10. Bancks MP, Lin M-Y, Bertoni A, et al. Impact of the COVID-19 pandemic on diabetes care among a North Carolina patient population. Clin Diabetes 2022;40:467–476.
11. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.
12. American Diabetes Association. Standards of medical care in diabetes - 2021. Diabetes Care 2021;44:S1–S232.
13. Eberly LA, Kallan MJ, Julien HM, et al. Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open 2020;3:e2031640.
14. Kakani P, Sorensen A, Quinton JK, et al. Patient characteristics associated with telemedicine use at a large academic health system before and after COVID-19. J Gen Intern Med 2021;36:1166–1168.
15. Reed ME, Huang J, Graetz I, et al. Patient characteristics associated with choosing a telemedicine visit vs office visit with the same primary care clinicians. JAMA Netw Open 2020;3:e205873.
16. Roberts ET, Mehrotra A. Assessment of disparities in digital access among Medicare beneficiaries and implications for telemedicine. JAMA Intern Med 2020;180:1386–1389.
17. Haynes SC, Kompala T, Neinstein A, et al. Disparities in telemedicine use for subspecialty diabetes care during COVID-19 shelter-in-place orders. J Diabetes Sci Technol 2021;15:986–992.
18. Trief PM, Izquierdo R, Eimicke JP, et al. Adherence to diabetes self care for white, African-American and Hispanic American telemedicine participants: 5 year results from the IDEATel project. Ethn Health 2013;18:83–96.
19. Mehrotra A, Chernew M, Linetsky D, et al. The impact of the COVID-19 pandemic on outpatient visits: practices are adapting to the new normal. https://www.commonwealthfund.org/publications/2020/jun/impact-covid-19-pandemic-outpatient-visits-practices-adapting-new-normal. Published June 25, 2020. Accessed October 3, 2023.
20. Chen Y, Sloan FA, Yashkin AP. Adherence to diabetes guidelines for screening, physical activity and medication and onset of complications and death. J Diabetes Complications 2015;29:1228–1233.
21. Bayer FJ, Galusha D, Slade M, et al. Process of care compliance is associated with fewer diabetes complications. Am J Manag Care 2014;20:41–52.
22. So CF, Chung JWY. Telehealth for diabetes self-management in primary healthcare: a systematic review and meta-analysis. J Telemed Telecare 2018; 24:356–364.
